@article{10272/24728,
year = {2025},
month = {1},
url = {https://hdl.handle.net/10272/24728},
abstract = {Background: The COVID-19 health crisis challenged healthcare systems around
the world, leading to restrictions in access to face-to-face healthcare services, and forcing
rapid adaptation to telehealth services. At present, there is a gap in the functioning of this
adaptation in drug-dependence centres. The present study analyses, over four years, care
indicators on the care modality (face-to-face vs. hybrid), the patient profile and the impact
on retention in treatment. Methods: Retrospective observational study with data collected
between 14 March 2019 and 21 June 2023. The electronic health records of 44,930 patients
were analysed according to different moments and selected based on the different health
measures imposed by the COVID-19 pandemic. Patients were classified according to
whether they received an in-person or hybrid intervention. Bivariate statistics and logistic
regression analysis were applied. Results: The trend over time shows an increase in
the number of patients seen in addiction centres. However, no notable changes within
the in-person care modality and a modest increase in telehealth services are observed.
Telehealth is primarily used among patients with opiate addiction, as well as with those
with comorbid mental disorders. Logistic regression analysis shows that patients in a
hybrid modality are more likely to remain in treatment. Conclusions: Results show that
hybrid care is associated with higher patient retention rates. Despite this, different profiles
are mostly treated with in-person interventions rather than hybrid modalities. Future
studies should explore how to generalise personalised hybrid care among SUD patients
considering factors such as patients’ educational level, employment status or accessibility
to mental health services.},
organization = {This work was supported by the grant “Evolución de la actividad asistencial y los resultados
del tratamiento de pacientes con trastorno por consume de sustancias en Andalucía durante las
diferentes fases de la pandemia COVID-19”, project EXP 2022/08882 by Delegación para el Gobierno
del Plan Nacional sobre Drogas (Spain) from the European Union’s Recovery, Transformation and
Resilicience Mechanism.},
publisher = {MDPI},
keywords = {Salud pública},
title = {Impact of COVID-19 on Substance Use Disorder Treatment: Examining the Influence of In-Person and Telehealth Intervention on Outcomes Using Real-World Data},
doi = {10.3390/healthcare13010084},
author = {Mancheño Velasco, Cinta and Narváez Camargo, Marta and Dacosta Sánchez, Daniel and Rosa Cáceres, Ana María and Lozano Rojas, Óscar Martín},
}